<DOC>
	<DOCNO>NCT00913640</DOCNO>
	<brief_summary>The investigator test whether prospective memory impaired individual Parkinson 's Disease compare control use reliable validated experimental measure . Also , investigator assess impact Parkinson 's medication prospective memory performance PD good estimate prospective memory function PD patient ' everyday ( chronically treat ) life .</brief_summary>
	<brief_title>Prospective Memory Parkinson 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>PD Group : Clinically definite PD 4070 year old Hoehn Yahr stage I , II , III Currently treat Levodopa/carbidopa Control Group : 4070 year old Spouses PD Group prefer PD Group Control Group : Significant neurological problem Significant current psychiatric diagnosis Mini Mental Status Exam score &lt; 24 ( MMSE ) Any significant abnormality brain image MPTP exposure Control Participants meet exclusion criterion describe well biological family history PD</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Prospective Memory Performance</keyword>
	<keyword>Prospective Memory Outcome</keyword>
	<keyword>Parkinson 's Disease</keyword>
</DOC>